224 related articles for article (PubMed ID: 20145133)
21. Ets2 transcription factor in normal and neoplastic human breast tissue.
Buggy Y; Maguire TM; McDermott E; Hill AD; O'Higgins N; Duffy MJ
Eur J Cancer; 2006 Mar; 42(4):485-91. PubMed ID: 16380248
[TBL] [Abstract][Full Text] [Related]
22. Cyclooxygenase-2 inhibition blocks M2 macrophage differentiation and suppresses metastasis in murine breast cancer model.
Na YR; Yoon YN; Son DI; Seok SH
PLoS One; 2013; 8(5):e63451. PubMed ID: 23667623
[TBL] [Abstract][Full Text] [Related]
23. ETS2 is involved in protein kinase C-activated expression of granulocyte-macrophage colony-stimulating factor in human non-small lung carcinoma cell line, A549.
Lu Z; Kim KA; Suico MA; Uto A; Seki Y; Shuto T; Isohama Y; Miyata T; Kai H
Biochem Biophys Res Commun; 2003 Mar; 303(1):190-5. PubMed ID: 12646185
[TBL] [Abstract][Full Text] [Related]
24. Gene expression analysis of macrophages that facilitate tumor invasion supports a role for Wnt-signaling in mediating their activity in primary mammary tumors.
Ojalvo LS; Whittaker CA; Condeelis JS; Pollard JW
J Immunol; 2010 Jan; 184(2):702-12. PubMed ID: 20018620
[TBL] [Abstract][Full Text] [Related]
25. Constitutive c-ets2 expression in M1D+ myeloblast leukemic cells induces their differentiation to macrophages.
Aperlo C; Pognonec P; Stanley ER; Boulukos KE
Mol Cell Biol; 1996 Dec; 16(12):6851-8. PubMed ID: 8943340
[TBL] [Abstract][Full Text] [Related]
26. Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion.
Williams TM; Medina F; Badano I; Hazan RB; Hutchinson J; Muller WJ; Chopra NG; Scherer PE; Pestell RG; Lisanti MP
J Biol Chem; 2004 Dec; 279(49):51630-46. PubMed ID: 15355971
[TBL] [Abstract][Full Text] [Related]
27. POU1F1 transcription factor promotes breast cancer metastasis via recruitment and polarization of macrophages.
Seoane S; Martinez-Ordoñez A; Eiro N; Cabezas-Sainz P; Garcia-Caballero L; Gonzalez LO; Macia M; Sanchez L; Vizoso F; Perez-Fernandez R
J Pathol; 2019 Nov; 249(3):381-394. PubMed ID: 31292963
[TBL] [Abstract][Full Text] [Related]
28. CSF1-ETS2-induced microRNA in myeloid cells promote metastatic tumor growth.
Mathsyaraja H; Thies K; Taffany DA; Deighan C; Liu T; Yu L; Fernandez SA; Shapiro C; Otero J; Timmers C; Lustberg MB; Chalmers J; Leone G; Ostrowski MC
Oncogene; 2015 Jul; 34(28):3651-61. PubMed ID: 25241894
[TBL] [Abstract][Full Text] [Related]
29. Ets2 maintains hTERT gene expression and breast cancer cell proliferation by interacting with c-Myc.
Xu D; Dwyer J; Li H; Duan W; Liu JP
J Biol Chem; 2008 Aug; 283(35):23567-80. PubMed ID: 18586674
[TBL] [Abstract][Full Text] [Related]
30. Identification of a subpopulation of macrophages in mammary tumor-bearing mice that are neither M1 nor M2 and are less differentiated.
Torroella-Kouri M; Silvera R; Rodriguez D; Caso R; Shatry A; Opiela S; Ilkovitch D; Schwendener RA; Iragavarapu-Charyulu V; Cardentey Y; Strbo N; Lopez DM
Cancer Res; 2009 Jun; 69(11):4800-9. PubMed ID: 19458073
[TBL] [Abstract][Full Text] [Related]
31. Stromal ETS2 Regulates Chemokine Production and Immune Cell Recruitment during Acinar-to-Ductal Metaplasia.
Pitarresi JR; Liu X; Sharma SM; Cuitiño MC; Kladney RD; Mace TA; Donohue S; Nayak SG; Qu C; Lee J; Woelke SA; Trela S; LaPak K; Yu L; McElroy J; Rosol TJ; Shakya R; Ludwig T; Lesinski GB; Fernandez SA; Konieczny SF; Leone G; Wu J; Ostrowski MC
Neoplasia; 2016 Sep; 18(9):541-52. PubMed ID: 27659014
[TBL] [Abstract][Full Text] [Related]
32. Altered Ets transcription factor activity in prostate tumor cells inhibits anchorage-independent growth, survival, and invasiveness.
Foos G; Hauser CA
Oncogene; 2000 Nov; 19(48):5507-16. PubMed ID: 11114728
[TBL] [Abstract][Full Text] [Related]
33. Ets2 and protein kinase C epsilon are important regulators of parathyroid hormone-related protein expression in MCF-7 breast cancer cells.
Lindemann RK; Braig M; Hauser CA; Nordheim A; Dittmer J
Biochem J; 2003 Jun; 372(Pt 3):787-97. PubMed ID: 12628005
[TBL] [Abstract][Full Text] [Related]
34. Ets-2 transdominant mutant abolishes anchorage-independent growth and macrophage colony-stimulating factor-stimulated invasion by BT20 breast carcinoma cells.
Sapi E; Flick MB; Rodov S; Kacinski BM
Cancer Res; 1998 Mar; 58(5):1027-33. PubMed ID: 9500466
[TBL] [Abstract][Full Text] [Related]
35. HOXB7 promotes malignant progression by activating the TGFβ signaling pathway.
Liu S; Jin K; Hui Y; Fu J; Jie C; Feng S; Reisman D; Wang Q; Fan D; Sukumar S; Chen H
Cancer Res; 2015 Feb; 75(4):709-19. PubMed ID: 25542862
[TBL] [Abstract][Full Text] [Related]
36. TFEB is a master regulator of tumor-associated macrophages in breast cancer.
Li Y; Hodge J; Liu Q; Wang J; Wang Y; Evans TD; Altomare D; Yao Y; Murphy EA; Razani B; Fan D
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32487570
[TBL] [Abstract][Full Text] [Related]
37. Identification of an integrated SV40 T/t-antigen cancer signature in aggressive human breast, prostate, and lung carcinomas with poor prognosis.
Deeb KK; Michalowska AM; Yoon CY; Krummey SM; Hoenerhoff MJ; Kavanaugh C; Li MC; Demayo FJ; Linnoila I; Deng CX; Lee EY; Medina D; Shih JH; Green JE
Cancer Res; 2007 Sep; 67(17):8065-80. PubMed ID: 17804718
[TBL] [Abstract][Full Text] [Related]
38. ETS2 and ERG promote megakaryopoiesis and synergize with alterations in GATA-1 to immortalize hematopoietic progenitor cells.
Stankiewicz MJ; Crispino JD
Blood; 2009 Apr; 113(14):3337-47. PubMed ID: 19168790
[TBL] [Abstract][Full Text] [Related]
39. miR-155 promotes macroscopic tumor formation yet inhibits tumor dissemination from mammary fat pads to the lung by preventing EMT.
Xiang X; Zhuang X; Ju S; Zhang S; Jiang H; Mu J; Zhang L; Miller D; Grizzle W; Zhang HG
Oncogene; 2011 Aug; 30(31):3440-53. PubMed ID: 21460854
[TBL] [Abstract][Full Text] [Related]
40. NCOA1 promotes angiogenesis in breast tumors by simultaneously enhancing both HIF1α- and AP-1-mediated VEGFa transcription.
Qin L; Xu Y; Xu Y; Ma G; Liao L; Wu Y; Li Y; Wang X; Wang X; Jiang J; Wang J; Xu J
Oncotarget; 2015 Sep; 6(27):23890-904. PubMed ID: 26287601
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
